Cancer Treatment Centers of America (CTCA) Hosts Medical Seminar on Key Cancer Research and Clinical Studies
Learn More About This Topic: Chat with Us | Email Us
ZION, IL, August 8, 2012 – Cancer Treatment Centers of America® (CTCA) is hosting its first ever CTCA REVIEW – a medical seminar featuring world renowned experts discussing key clinical data presented at major scientific meetings including the 2012 American Society of Hematology (ASH) & American Society of Clinical Oncology (ASCO) annual meetings.
The two-day CTCA REVIEW, Advances & Controversies In Malignant Hematology & Oncology, will be held September 7-8, 2012 at the Trump International Hotel & Tower in Chicago, IL. The course provides medical professionals the opportunity to receive an in-depth look into highly specialized subject matter that relates directly to their areas of expertise and will aid them in making better treatment decisions for their patients. The seminar is formatted to encourage open exchange and dialog, and includes interactive and patient case presentations, faculty panel discussions and question and answer sessions.
“The use of case studies, patient management scenarios and similar resources, allows physicians and other allied health care professionals the opportunity to have a more personalized, interactive experience with some of the leading medical minds in the hematology and oncology world,” said Hematology Program Chair Syed A. Abutalib, MD, Assistant Director, Stem Cell Transplant and Cell Therapy Program, CTCA at Midwestern Regional Medical Center (Midwestern).
The seminar offers both a hematology and oncology track.
The following are among the 11 hematology track faculty of experts featured at the CTCA REVIEW:
- Ken Anderson, MD, Dana-Farber Cancer Institute
- Robert A. Kyle, MD, Mayo Clinic
- Istvan Redei, MD, Cancer Treatment Centers of America
- Susan M. O’Brien, MD, MD Anderson Cancer Center
The seminar also offers an oncology track, with 13 of the country’s leading authorities in the field including:
- Maurie Markman, MD, Cancer Treatment Centers of America
- Ronald M. Bukowski, MD, Cleveland Clinic Taussig Cancer Center
- Julie R. Gralow, MD, University of Washington School of Medicine and Seattle Cancer Care Alliance
- Richard F. Riedel, MD, Duke University Medical Center
“Those attending this seminar will not only better understand and interpret the most recently presented data in the fields of hematology and oncology, but also be able to incorporate this information into their current practice and patient care model”, noted Dr. Abutalib.
The CTCA REVIEW offers CME certificates, awarding AMA PRA Category 1 Credit™ or certificates documenting attendance. CME webcasts and abbreviated slide decks from all faculty presenting at the CTCAREVIEW will be available at www.ctcareviewcme.org. Registration and course information is available at www.ctcareviewcme.org.
# # #
Editor’s Note: Link to Conference Agenda
About Cancer Treatment Centers of America
Cancer Treatment Centers of America, Inc. (CTCA) is a national network of hospitals focusing on complex and advanced stage cancer. CTCA offers a comprehensive, fully integrated approach to cancer treatment and serves patients from all 50 states at facilities located in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Known for delivering the Mother Standard® of care and Patient Empowerment Medicine®, CTCA provides patients with information about cancer and their treatment options so they can control their treatment decisions. For more information about CTCA, go to www.cancercenter.com.
